Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2014-12-15 (11 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BREST (29200), Finistere
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE SAINT MARC : revenue, balance sheet and financial ratios
PHARMACIE SAINT MARC is a French company
founded 11 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BREST (29200),
this company of category PME
shows in 2024 a net income positive of 90 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE SAINT MARC (SIREN 808415673)
Indicator
2024
2023
2022
2021
2020
2019
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
90 011 €
42 634 €
167 738 €
152 559 €
106 693 €
128 133 €
150 492 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE SAINT MARC generates positive net income of 90 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 150 k€ -> 90 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
90 011 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 92%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 45%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
92.38%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
45.365%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE SAINT MARC
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2019
2020
2021
2022
2023
2024
Debt ratio
354.749
320.181
237.919
170.06
126.006
116.107
92.38
Financial autonomy
19.464
21.575
25.98
32.643
38.934
40.217
45.365
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
92.382024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average
In 2024, the debt ratio of PHARMACIE SAINT MARC (92.38) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
45.37%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average+6 pts over 3 years
In 2024, the financial autonomy of PHARMACIE SAINT MARC (45.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 179.54. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
179.541
Liquidity indicators evolution PHARMACIE SAINT MARC
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2019
2020
2021
2022
2023
2024
Liquidity ratio
177.266
207.005
186.811
208.916
217.633
183.336
179.541
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
179.542024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average-7 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE SAINT MARC (179.54) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of PHARMACIE SAINT MARC in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE SAINT MARC is estimated at
1 256 620 €
(range 875 090€ - 1 879 975€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
875k€1256k€1879k€
1 256 620 €Range: 875 090€ - 1 879 975€
NAF 5 année 2024
Valuation method used
Net Income Multiple
90 011 €
×
14.0x
=1 256 620 €
Range: 875 090€ - 1 879 976€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE SAINT MARC with other companies in the same sector:
Frequently asked questions about PHARMACIE SAINT MARC
What is the revenue of PHARMACIE SAINT MARC ?
The revenue of PHARMACIE SAINT MARC is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE SAINT MARC profitable?
Yes, PHARMACIE SAINT MARC generated a net profit of 90 k€ in 2024.
Where is the headquarters of PHARMACIE SAINT MARC ?
The headquarters of PHARMACIE SAINT MARC is located in BREST (29200), in the department Finistere.
Where to find the tax return of PHARMACIE SAINT MARC ?
The tax return of PHARMACIE SAINT MARC is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE SAINT MARC operate?
PHARMACIE SAINT MARC operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart